Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction
Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction: a Prospective, Multicenter, Observational Cohort Study
Sponsor: Dongguan People's Hospital
This observational or N/A phase trial investigates Stroke and is currently actively recruiting participants. Dongguan People's Hospital leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Jun 2025 — Present [monthly]
Not Yet Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Dongguan People's Hospital
- Fujian Medical University Union Hospital
- Ganzhou City People's Hospital
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Guangzhou Medical University
- Haikou People's Hospital
- Hainan People's Hospital
- Hainan Traditional Chinese Medicine Hospital
- Huadu District People's Hospital of Guangzhou
- Huizhou Municipal Central Hospital
- Kashgar 1st People's Hospital
- Nanfang Hospital, Southern Medical University
- Second Affiliated Hospital of Guangxi Medical University
- Second Affiliated Hospital of Wenzhou Medical University
- Sinopharm North Hospital
- The Affiliated Hospital of Inner Mongolia Medical University
- The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
- The Second Hospital University of South China
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Baotou, China , Changsha, China , Dongguan, China , Fuzhou, China , Ganzhou, China , Guangzhou, China , Haikou, China , Hengyang, China , Heyuan, China , Hohhot, China and 4 more locations